Kestra Medical Technologies (KMTS) shares rose in their debut on Nasdaq Thursday after the company priced its initial public offering of about 11.9 million shares at $17.00 per share.
The shares were up over 30% at $22.13 in recent trading after opening at $22.95.
Underwriters, including BofA Securities and Goldman Sachs, will have a 30-day option to buy up to almost 1.8 million additional shares, Kestra said. The offering is expected to close Friday.
Price: 22.35, Change: +5.35, Percent Change: +31.44
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。